Jump to main content
Jump to site search

Issue 15, 2018
Previous Article Next Article

Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands

Author affiliations

Abstract

Metastasis displays a highly heterogeneous cellular population with cancer cells continuously evolving. As a result, a single-ligand nanoparticle cannot account for the continuously changing expression of targetable biomarkers over time and space. To effectively direct nanoparticles to metastasis, we developed a multi-ligand nanoparticle by using four different types of ligands on the same nanoparticle that target biomarkers on the endothelium associated with metastatic disease. These vascular targets included αvβ3 integrin, P-selectin, EGFR and fibronectin. Using terminal and in vivo imaging studies, the targeting performance of the multi-ligand nanoparticles was compared to the single-ligand nanoparticle variants. All four single-ligand nanoparticle variants achieved significant targeting of lung metastasis in the 4T1 mouse model of breast cancer metastasis with about 2.5% of the injected dose being deposited into metastasis. A dual-ligand nanoparticle resulted in a nearly 2-fold higher deposition into lung metastases than its single-ligand counterparts. The multi-ligand nanoparticle significantly outperformed its targeting nanoparticle counterparts achieving a deposition of ∼7% of its injected nanoparticles into lung metastases. Using the high sensitivity of radionuclide imaging, PET imaging showed that a multi-ligand nanoparticle labeled with [18F]fluoride was able to precisely target metastatic disease at its very early stage of development in three different animal models of metastatic breast cancer.

Graphical abstract: Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands

Back to tab navigation

Supplementary files

Publication details

The article was received on 20 Oct 2017, accepted on 29 Mar 2018 and first published on 29 Mar 2018


Article type: Communication
DOI: 10.1039/C8NR02513D
Citation: Nanoscale, 2018,10, 6861-6871
  •   Request permissions

    Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands

    P. M. Peiris, F. He, G. Covarrubias, S. Raghunathan, O. Turan, M. Lorkowski, B. Gnanasambandam, C. Wu, W. P. Schiemann and E. Karathanasis, Nanoscale, 2018, 10, 6861
    DOI: 10.1039/C8NR02513D

Search articles by author

Spotlight

Advertisements